Homocysteine is a bystander for ST-segment elevation myocardial infarction: a case-control study

BACKGROUND: Homocysteine has been long considered a risk factor for atherosclerosis. However, cardiovascular events cannot be reduced through homocysteine lowering by B vitamin supplements. Although several association studies have reported an elevation of serum homocysteine levels in cardiovascular...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Ching-Yu Julius, Yang, Tzu-Ching, Chang, Christopher, Lu, Shao-Chun, Chang, Po-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5809814/
https://www.ncbi.nlm.nih.gov/pubmed/29433446
http://dx.doi.org/10.1186/s12872-018-0774-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5809814/
https://www.ncbi.nlm.nih.gov/pubmed/29433446
http://dx.doi.org/10.1186/s12872-018-0774-8

Ejemplares similares